GL1X · GenesisL1 explorer

Research workbench

Design and preparation of potent, non-peptidic, bioavailable renin inhibitors

Analyse Design and preparation of potent, non-peptidic, bioavailable renin inhibitors in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3G6Z
Type
protein
Length
671 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Renin
EC
3.4.23.15
UniProt
P00797
Ligands
A7T, NAG
Pockets
4 · best druggability 0.78

Structure

x-ray diffraction · 2 distinct chains · 15% helix, 45% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARenin (EC 3.4.23.15)protein33714% helix, 44% strandP00797
BRenin (EC 3.4.23.15)protein33416% helix, 45% strandP00797

Ligands and binding sites

  • A7T · (1R,5S)-N-cyclopropyl-7-{4-[2-(2,6-dichloro-4-methylphenoxy)ethoxy]phenyl}-N-(2,3-dimethylbenzyl)-3,9-diazabicyclo[3.3.1]non-6-ene-6-carboxamide · ligand · 2 copies · chains A, B
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111600.780.8096A7T
211730.740.7776A7T
31000.380.7622empty
4670.340.7717empty

Interfaces

1 interface between chains.

  • A–B · 783 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide, 3 glycan (disulfide, N-glycosylation).

Compared structures

  • 3G6Z · Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.